Popular strategy for raising pregnancy rates in IVF fails to deliver improvement in large trial

The increasingly popular trend for fertility clinics to freeze all IVF embryos for later transfer has been shown in a large multicentre randomised trial to offer no improvement in delivery rates over traditional 'fresh' embryo transfers. "Our findings give no support to a general freeze-all strategy in normally menstruating women," said investigator Dr. Sacha Stormlund from Copenhagen University Hospital in Denmark, who presents the results today at the 35th Annual Meeting of ESHRE.

"The results of this trial were as we expected," said Dr. Stormlund, 'namely, to see similar pregnancy rates between the fresh and freeze-all treatment groups. So I think it can now plausibly be said that there is no indication for a general freeze-all strategy in women with regular menstrual cycles who are not at immediate risk of overstimulation in IVF."

Behind the study lies an increasingly adopted strategy in assisted reproduction to freeze all embryos generated in a first cycle and transfer them after thawing in a later cycle (rather than as fresh embryos in the initial cycle). Some from registries in Japan and USA have suggested that there are now more frozen in IVF than fresh, with numbers still growing and many clinics claiming that outcomes can be improved with a freeze-all approach. However, despite the enthusiasm of clinics, most study results investigating the freeze-all vs fresh controversy have been inconsistent in their results.

This study, which aimed to test the claim of improved outcome in a general IVF patient population, was a large randomised trial involving 460 IVF at eight clinics in Denmark, Sweden and Spain and powered to provide a robust result. The patients were randomly assigned to test the two different treatment approaches, both of them with single blastocyst transfer: freeze-all with frozen embryo transfer in a subsequent cycle versus the with fresh transfer.

Results showed that the ongoing pregnancy per randomised patient after the first single blastocyst transfer was similar in the two groups: 26.1% in the freeze-all group and 28.8% in the fresh transfer group, a statistically non-significant difference suggesting that a general freeze-all policy will bring no patient benefit in terms of pregnancy outcome. Live birth rates were also comparable.

"I think we can now reasonably say, based on our results and those from other recent trials, that in normally ovulating patients there is no apparent benefit from a freeze-all strategy in IVF," said Dr. Stormlund. "However, the evidence derived from another large trial in women with and at risk of responding excessively to stimulation suggests a considerable freeze-all benefit both in terms of live birth and ovarian hyperstimulation syndrome."

This latter component of safety was an additional secondary endpoint to the study. In the freeze-all cycles ovulation of the mature eggs was triggered with a reproductive hormone-suppressing drug known as a GnRH agonist; in the conventional fresh transfer group ovulation was triggered traditionally with hCG. And in this part of the study there was an apparent patient benefit from the freeze-all approach in terms of patient safety. Twenty-five of the 220 patients in the fresh transfer group were judged at risk of ovarian hyperstimulation syndrome (OHSS) towards the end of their treatment cycle and, to remove the risk, they were switched to the freeze-all group.

"The occurrence of OHSS was not systematically assessed in women allocated to the freeze-all group," explained Dr. Stormlund, 'as any risk in this group was practically eliminated. Indeed, there were no signs of OHSS in the freeze-all group. The 25 patients judged at high risk of OHSS in the fresh transfer group were swopped from the fresh to the freeze-all group as a safety measure and according to trial protocol."

The latest European figures from ESHRE put the reported incidence of OHSS at 0.3%, making it the most common complication of IVF. "However," said Dr. Stormlund, 'in a recent study from our group in Denmark, we found a considerably higher rate of severe OHSS of 5.1%. That's why in this study we aimed to reduce the risk of OHSS with a freeze-all plan with GnRH trigger and a cancellation policy in the fresh embryo group for women at high risk of OHSS."

However, Dr. Stormlund insisted that there is still no reason to recommend the freeze-all strategy for patients not at immediate risk of OHSS. Only in patients with anovulatory infertility should an immediate freeze-all strategy be considered. "At present," she said, 'there is only sufficient evidence to recommend freeze-all for patients diagnosed with polycystic ovary syndrome. Otherwise, in women with regular cycles, we see no benefit."

Explore further

Benefits from freeze-all embryo strategy in older IVF patients

Citation: Popular strategy for raising pregnancy rates in IVF fails to deliver improvement in large trial (2019, June 24) retrieved 11 August 2022 from https://medicalxpress.com/news/2019-06-popular-strategy-pregnancy-ivf-large.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors